Effects of prolactin inhibition during late gestation on the immunity of gilts and foetuses

Canadian Journal of Animal Science

Volumn 85, Issue 3, 2005, Pages 335-343

  Lessard, M ^a   Dupuis, M ^a   Farmer, C ^a  

^a AGRICULTURE AND AGRI FOOD CANADA   (Canada)

Author keywords

Bromocriptine; Immunity; Pregnancy; Prolactin; Sow

Indexed keywords

SUS SCROFA;

EID: 28044457187     PISSN: 00083984     EISSN: None     Source Type: Journal    
DOI: 10.4141/A04-068     Document Type: Article

References (37)

1. Agriculture and Agri-Food Canada. 1993. Recommended code of practice for the care and handling of farm animals - pigs. Publ. No. 1898E. Agriculture and Agri-Food Canada, Ottawa, ON.
2. Bazer, F. W., Goldstein, M. H. and Barron, D. H. 1981. Water and electrolyte transport by pig chorioallantois. Pages 299-321 in L. Mastroianni and J. D. Biggers, eds. Fertilization and embryonic development in vitro. Plenum Publ. Corp., New York, NY.
3. Bernton, E. W., Meltzer, M. S. and Holaday, J. W. 1988. Suppression of macrophage activation and T-lymphocyte function in hypoprolactinemic mice. Science 239: 401-404.
4. Bernton, E. W., Beach, J. E., Holaday, J. W., Smallridge, R. C. and Fein, H. G. 1987. Release of multiple hormones by a direct action of interleukin-1 on pituitary cells. Science 238: 519-521.
5. Bouchard, B., Ormandy, C. J., Di Santo, J. P. and Kelly, P. A. 1999. Immune system development and function in prolactin receptor-deficient mice. J. Immunol. 163: 576-582.
6. Brown-Borg, H. M., Blecha, F. and Klemcke, H. G. 1997. Influence of plasma prolactin concentrations and age on neonatal immune function. Comp. Biochem. Physiol. 118A: 821-829.
7. Dogusan, Z., Book, M. L., Verdood, P., Yu-Lee, L. Y. and Hooghe-Peters, E. L. 2000. Prolactin activates interferon regulatory factor-1 expression in normallympho-hemopoietic cells. Eur. Cytokine Netw. 11: 435-442
8. Farmer, C. and Petitclerc, D. 2003. Specific window of prolactin inhibition in late gestation decreases mammary parenchymal tissue development in gilts. J. Anim. Sci. 81: 1823-1829.
9. Farmer, C., Palin, M. F. and Sorensen, M. T. 2000. Mammary gland development and hormone levels in pregnant Upton-Meishan and Large White gilts. Domest. Anim. Endocrinol. 18: 241-251.
10. Farmer, C., Robert, S. and Rushen, J. 1998. Bromocriptine given orally to periparturient of lactating sows inhibits milk production. J. Anim. Sci. 76: 750-757.
11. Feng, J. C., Loh, T. T. and Sheng, H. P. 1998. Lactation increases prolactin receptor expression in spleen and thymus of rats. Life Sci. 63: 111-119.
12. Freemark, M., Kirk, K., Pihoker C., Robertson, M. C., Shiu, R. P. and Driscoll, P. 1993. Pregnancy lactogens in the rat conceptus and fetus: circulating levels, distribution of binding, and expression of receptor messenger ribonucleic acid. Endocrinology 133: 1830-1842.
13. Gaufo, G. O. and Diamond, M. C. 1996. Prolactin increases CD4/CD8 cell ratio in thymus-grafted congenitally athymic nude mice. Proc. Natl. Acad. Sci. 93: 4165-4169.
14. Goffin, V., Binart, N., Touraine, P. and Kelly, P. A. 2002. Prolactin: The new biology of an old hormone. Ann. Rev. Physiol. 64: 47-67.
15. Horth, S. and Farmer, C. 2000. Hormonal changes in gilts receiving bromocriptine orally during gestation. Can. J. Anim. Sci. 80: 373-376.
16. Kadioglu, P., Acbay, O., Demir, G., Gazioglu, N. and Gundogdu, S. 2001. The effect of prolactin and bromocriptine on human peripheral immune status. J. Endocrinol. Invest. 24: 147-151.
17. Klindt, J. and Stone, R. T. 1984. Porcine growth hormone and prolactin: concentrations in the fetus and secretory patterns in the growing pig. Growth 48: 1-15.
18. Leonard, W. J. and O'Shea, J. J. 1998. Jaks and STATs: biological implications. Annu. Rev. Immunol. 16: 293-322.
19. Luppi, P. 2003. How immune mechanisms are affected by pregnancy. Vaccine 21: 3352-3357.
20. Mallard, B. A., Wagter, L. C., Ireland, M. J. and Dekkers, J. C. 1997. Effects of growth hormone, insulin-like growth factor-I, and cortisol on periparturient antibody response profiles of dairy cattle. Vet. Immunol. Immunopathol. 60: 61-76.
21. McKenna, F., McLaughlin, P. J., Lewis, B. J., Sibbring, G. C., Cummerson, J. A., Bowen-Murphy, W. J., Rui, H. and Longo, D. L. 1995. Effects of growth hormone and prolactin immune development and function. Life Sci. 57: 1-14.
22. Morikawa, K., Oseko, F. and Morikawa, S. 1993. Immunosuppressive property of bromocriptine on human B lymphocyte function in vitro. Clin. Exp. Immunol. 93: 200-205.
23. Morikawa, K., Oseko, F. and Morikawa, S. 1994. Immunosuppressive activity of bromocriptine on human T lymphocyte function in vitro. Clin. Exp. Immunol. 95: 514-518.
24. Nagy, E., Berczi, I., Wren, G. E., Asa, S. L. and Kovacs K. 1983. Immunomodulation by bromocriptine. Immunopharmacology 6: 231-243.
25. Neidhart, M. 1997. Bromocriptine has little direct effect on murine lymphocytes, the immunomodulatory effect being mediated by the suppression of prolactin secretion. Biomed Pharmacother. 51: 118-125.
26. Richards, S. M., Garman, R. D., Keyes, L., Kavanagh, B. and Mcpherson, J. M. 1998. Prolactin is an antagonist of TGF-beta activity and promotes proliferation of murine B cell hybridomas. Cell. Immunol. 184: 85-91.
27. Reusens, B., Kuhn, E. R. and Hoet, J. J. 1979. Fetal plasma prolactin levels and fetal growth in relation to maternal CB-154 treatment in the rat. Gen. Comp. Endocrinol. 39: 118-120.
28. Rovensky, J., Vigas, M., Marek, J., Blazickova, S., Korcakova, L., Vyletelkova L. and Takac, A. 1991. Evidence for immunomodulatory properties of prolactin in selected in vitro and in vivo situations. Int. J. Immunopharmacol. 13: 267-272.
29. Russell, D. H., Mills, K. T., Talamantes, F. J. and Bern, H. A. 1988. Neonatal administration of prolactin antiserum alters the developmental pattern of T- and B-lymphocytes in the thymus and spleen of BALB/c female mice. Proc. Natl. Acad. Sci. 85: 7404-7407.
30. SAS Institute, Inc. 2000. Release 8.02. SAS Institute, Inc., Cary, NC.
31. Spangelo, B. L., Hall, N. R., Ross, P. C. and Goldstein, A. L. 1987. Stimulation of in vivo antibody production and concanavalin-A-induced mouse spleen cell mitogenesis by prolactin. Immunopharmacology 14: 11-20.
32. Tucker, H. A. 1985. Endocrine and neural control of the mammary gland. In B. L. Larson, ed. Lactation. The Iowa State University Press, Ames, IA.
33. Ullrey, D. E., Sprague, J. I., Becker, D. E. and Miller E. R. 1965. Growth of the swine fetus. J Anim Sci. 24: 711-717.
34. Vidaller, A., Guadarrama, F., Llorente, L., Mendez, J. B., Larrea, F., Villa, A. R. and Alarcon-Segovia, D. 1992. Hyperprolactinemia inhibits natural killer (NK) cell function in vivo and its bromocriptine treatment not only corrects it but makes it more efficient. J. Clin. Immunol. 12: 210-215.
35. Yang, L., Lii, S., Kuo, B., Buckley, A., Buckley, D., Chen, C., Xu, X., Coss, D. and Walker, A. M. 2002. Maternal prolactin composition can permanently affect epidermal γdeltaT cell function in the offspring. Dev. Comp. Immunol. 26: 849-860.
36. Yu-Lee, L. Y. 1997. Molecular actions of prolactin in the immune system. Proc. Soc. Exp. Biol. Med. 215: 35-52.
37. Yu-Lee, L.-Y., Luo, G. Y., Book, M. L. and Morris, S. M. 1998. Lactogenic hormone signal transduction. Biol. Reprod. 58: 295-301.